Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 34, Issue 18, 2016, Pages 2133-2140

  Liu, Chengcheng ^a   Yang, Wenjian ^a   Devidas, Meenakshi ^c   Cheng, Cheng ^a   Pei, Deqing ^a   Smith, Colton ^a   Carroll, William L ^d   Raetz, Elizabeth A ^e   Bowman, W Paul ^f   Larsen, Eric C ^h   Maloney, Kelly W ⁱ   Martin, Paul L ^j   Mattano, Leonard A ^k   Winick, Naomi J ^g   Mardis, Elaine R ^l   Fulton, Robert S ^l   Bhojwani, Deepa ^m   Howard, Scott C ^b   Jeha, Sima ^a   Pui, Ching Hon ^a   Hunger, Stephen P ^o   Evans, William E ^a   Loh, Mignon L ⁿ   Relling, Mary V ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f Cook Children's Hospital ^*  (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h Maine Children's Cancer Program Scarborough   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j DUKE UNIVERSITY   (United States)

^k HARP Pharma Consulting   (United States)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m CHILDREN S HOSPITAL LOS ANGELES   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE MACROGOL; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE A2; UNCLASSIFIED DRUG; ASPARAGINASE; CARBOXYPEPTIDASE A;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGE; AMERICAN INDIAN; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PURINE METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; ACUTE DISEASE; CHILD; COMPLICATION; GENETICS; INFANT; NEWBORN; PANCREATITIS; PRESCHOOL CHILD; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ASPARAGINASE; CARBOXYPEPTIDASES A; CHILD; CHILD, PRESCHOOL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; PANCREATITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84973645177     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.64.5812     Document Type: Article

References (45)

1. Knoderer HM, Robarge J, Flockhart DA: Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer 49:634-639, 2007
2. Samarasinghe S, Dhir S, Slack J, et al: Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol 162:710-713, 2013
3. Silverman LB, Gelber RD, Dalton VK, et al: Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. Blood 97:1211-1218, 2001
4. Raja RA, Schmiegelow K, Albertsen BK, et al: Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol. Br J Haematol 165:126-133, 2014
5. Flores-Caldero´n J, Exiga-Gonzale´z E, Morán- Villota S, et al: Acutepancreatitisinchildrenwithacute lymphoblastic leukemia treated with L-asparaginase. J Pediatr Hematol Oncol 31:790-793, 2009
6. Vrooman LM, Stevenson KE, Supko JG, et al: Postinduction dexamethasone and individualized dosing ofEscherichia ColiL-asparaginase eachimprove outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: Results from a randomized study - Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 31:1202-1210, 2013
7. Moghrabi A, Levy DE, Asselin B, et al: Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109:896-904, 2007
8. Avramis VI, Sencer S, Periclou AP, et al: A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study. Blood 99: 1986-1994, 2002
9. Raja RA, Schmiegelow K, Frandsen TL: Asparaginase-associated pancreatitis in children. Br J Haematol 159:18-27, 2012
10. Sadr-Azodi O, Mattsson F, Bexlius TS, et al: Association of oral glucocorticoid use with an increased risk of acute pancreatitis: A population-based nested case-control study. JAMA Intern Med 173:444-449, 2013
11. Halalsheh H, Bazzeh F, Alkayed K, et al: 6- Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma. J Pediatr Hematol Oncol 35:470-472, 2013
12. Trivedi CD, Pitchumoni CS: Drug-induced pancreatitis: An update. J Clin Gastroenterol 39:709-716, 2005
13. Silverman LB, Stevenson KE, O'Brien JE, et al: Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 24:320-334, 2010
14. Weetman RM, Baehner RL: Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 34:780-785, 1974
15. Alvarez OA, Zimmerman G: Pegaspargaseinduced pancreatitis. Med Pediatr Oncol 34:200-205, 2000
16. Whitcomb DC, LaRusch J, Krasinskas AM, et al: Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 44:1349-1354, 2012
17. Schneider A, Larusch J, Sun X, et al: Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology 140:162-171, 2011
18. Witt H, Luck W, Hennies HC, et al: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213-216, 2000
19. Szmola R, Sahin-To´th M: Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci USA 104:11227-11232, 2007
20. Sharer N, Schwarz M, Malone G, et al: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645-652, 1998
21. Felderbauer P, Hoffmann P, Einwächter H, et al: A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol 3:34, 2003
22. Heap GA, Weedon MN, Bewshea CM, et al: HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet 46:1131-1134, 2014
23. Felderbauer P, Klein W, Bulut K, et al: Mutations in the calcium-sensing receptor: A new genetic risk factor for chronic pancreatitis? Scand J Gastroenterol 41:343-348, 2006
24. Mounzer R, Whitcomb DC: Genetics of acute and chronic pancreatitis. Curr Opin Gastroenterol 29: 544-551, 2013
25. Pui CH, Sandlund JT, Pei D, et al: Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104:2690-2696, 2004
26. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
27. Borowitz MJ, Devidas M, Hunger SP, et al: Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study. Blood 111:5477-5485, 2008
28. Borowitz MJ, Wood BL, Devidas M, et al: Prognostic significance of minimal residual disease in high risk B-ALL: A report from Children's Oncology Group study AALL0232. Blood 126:964-971, 2015
29. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data (ed 2). New York, John Wiley & Sons, 2002.
30. Yang JJ, Cheng C, Devidas M, et al: Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 43:237-241, 2011
31. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
32. Ionita-Laza I, Lee S, Makarov V, et al: Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet 92:841-853, 2013
33. Silverman LB, Stevenson K, Vrooman LM, et al: Randomized comparison of IV peg and IM E. coli asparaginase in children and adolescents with acute lymphoblastic leukemia: Results of the DFCI ALL consortium protocol 05-01. Blood 118:398-399, 2011
34. Dhall G, Robison NJ, Rubin JI, et al: Incidence of adverse reactions to post-induction asparaginase (ASP) therapy in children and adolescents with high-risk acute lymphoblastic leukemia (ALL): A report from the Children's Oncology Group Study CCG-1961, J Clin Oncol 26, 2008 (suppl; abstr 10021)
35. Exome Aggregation Consortium (ExAC) data set. http://exac.broadinstitute.org
36. Tenner S, Baillie J, DeWitt J, et al: American College of Gastroenterology guideline: Management of acute pancreatitis. Am J Gastroenterol 108:1400- 1415; 1416, 2013
37. Catasús L, Vendrell J, Avilés FX, et al: The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model. J Biol Chem 270:6651-6657, 1995
38. Witt H, Beer S, Rosendahl J, et al: Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 45:1216-1220, 2013
39. Belostotsky R, Seboun E, Idelson GH, et al: Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87:392-399, 2010
40. Monico CG, Rossetti S, Belostotsky R, et al: Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol 6: 2289-2295, 2011
41. Jiang J, Johnson LC, Knight J, et al: Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am J Physiol Gastrointest Liver Physiol 302:G637-G643, 2012
42. Niederau C, Niederau M, Lüthen R, et al: Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology 99:1120-1127, 1990
43. Frick TW: The role of calcium in acute pancreatitis. Surgery 152:S157-S163, 2012 (suppl 1)
44. Ueda T, Takeyama Y, Kaneda K, et al: Protective effect of a microtubule stabilizer taxol on caerulein-induced acute pancreatitis in rat. J Clin Invest 89:234-243, 1992
45. Vora A, Goulden N, Mitchell C, et al: Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediaterisk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial. Lancet Oncol 15: 809-818, 2014